ArticleFrontiers in pediatrics2026
Segmented filamentous bacteria are associated with disease activity in children with inflammatory bowel disease.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to determine the positivity rate of segmented filamentous bacteria (SFB) in pediatric patients with inflammatory bowel disease (IBD) and to evaluate its association with disease activity. Methods: In this cross-sectional study, 30 pediatric IBD patients and 30 children with functional gastrointestinal disorders were enrolled. SFB in ileal lavage fluid from the terminal ileum were detected using polymerase chain reaction. IBD patients were stratified according to treatment status and disease activity-Untreated Active (UTA), Treated Remission (TRR), Treated Active (TRA)-as well as by disease type (Crohn's disease or ulcerative colitis). SFB positivity rates were compared across subgroups. Within the IBD cohort, disease activity and inflammatory markers, including fecal calprotectin, C-reactive protein, erythrocyte sedimentation rate, platelets count, were compared between SFB-positive and SFB-negative patients. Results: The SFB positivity rate was significantly higher in pediatric IBD patients than in controls (63.3% vs. 36.7%, Conclusions: SFB positivity occurred more frequently in pediatric IBD than in controls-especially in active disease-and was associated with higher inflammatory activity and disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.